	Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer. Oncoimmunology Yucel MH, Mildanoglu MM, Engin Delipoyraz E, Ozcelik H, Sunger E, Fidan S, Terzioglu C, Cakir T, Muglu H, Cakan Demirel B, Hamdard J, Kutlu Y, Ac, Seker M, Bilici A. PMID: 42788839 [PubMed - indexed for MEDLINE]
	Evaluation of the Systemic Immune-Inflammation Index, Neutrophil-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients Diagnosed with Lung Cancer by Bronchoscopy in Relation to Disease Stage and PET/CT SUVmax. World J Nucl Med Kaya , Kurt N, Erbay Ü, Parspur , Mar, Do, Kaya . PMID: 42787882 [PubMed]
	Meta-analysis of the changes in clinical features and characteristics of lung cancer under bronchoscopy. Am J Clin Exp Immunol Wang L, Zhou J, Hu R. PMID: 42787643 [PubMed]
	The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials. Front Immunol Huang Y, Ma J, Bi J, Pi G, Li Y, Peng Y, Xiao C, Tuo X, Han G. PMID: 42787504 [PubMed - indexed for MEDLINE]
	The oral-lung axis in lung cancer: microbial translocation, immune reprogramming, and clinical implications. Front Immunol Liu X, Ding G, Lu J, Song W, Li Y, Chen X, Cui J. PMID: 42787422 [PubMed - indexed for MEDLINE]
	The association of the advanced lung cancer inflammation index with the risk of Helicobacter pylori infection and mortality: a study of populations from two countries. Front Cell Infect Microbiol Hu Q, Zhu H, Wei Q, Shen Q, Xiong M, Huang S. PMID: 42787355 [PubMed - indexed for MEDLINE]
	Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer. Front Immunol Cui P, Lin X, Luo W, Zhang S, Zhang S, Xu S, Lai J, Xiong Y, Chen D, Huang B, Xu Z. PMID: 42787263 [PubMed - indexed for MEDLINE]
	Efficacy and safety of risk-adapted modified stereotactic body radiotherapy for lung tumors: a single-institution retrospective study. J Radiat Res Oka A, Yamashita H, Miki Y, Sawayanagi S, Nozawa Y, Sugahara D, Hayashi T, Suzuki T, Katano A. PMID: 42786599 [PubMed - as supplied by publisher]
	Longitudinal spatial multi-omics delineates tumor microenvironment remodeling across sequential EGFR-TKIs in EGFR-mutant NSCLC. J Transl Med Song X, Pan C, Li Z, Zhou X, Xiong A, Zhao Z, Luo H, Zhou C. PMID: 42786513 [PubMed - indexed for MEDLINE]
	AdvanTIG-105: a phase I/Ib dose-expansion study of ociperlimab plus tislelizumab with or without chemotherapy in metastatic non-small cell lung cancer and extensive-stage small cell lung cancer. J Immunother Cancer Lu S, Yu Y, Zhang J, Wang Q, Cho EK, Zhao J, Kim SH, Lee Y, Clay TD, Yang TY, Chang GC, Yang H, Zuo Y, Liu R, Sun P, Kim HR. PMID: 42785919 [PubMed - indexed for MEDLINE]
	Patient Experiences With a Symptom Monitoring and Self-Referral Program for Specialty Palliative Care After Lung Cancer Diagnosis: Qualitative Study. JMIR Form Res Agne JL, Gaughan AA, Rush LJ, Eramo JL, Sinclair A, Grogan MM, Merlin JS, Stevens J, Cronin RM, Padamsee TJ, Presley CJ, McAlearney AS. PMID: 42785736 [PubMed - indexed for MEDLINE]
	Additive local radical therapy in synchronous oligometastatic non-small cell lung cancer without oncogenic drivers: a single-center retrospective cohort study. Cancer Treat Res Commun Aßmann MD, Aust MH, Rades D, Drömann D, Bohnet S, Franzen KF. PMID: 42785040 [PubMed - as supplied by publisher]
	Gap Between Estimated Need and Observed Uptake of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Among Patients With Lung Cancer in Indonesia. JCO Glob Oncol Asmara OD, Tenda ED, Radityamurti F, Indirawati NN, Wijaya IPEK, Habib H, Herikurniawan H, Yulianti M, Singh G, Kamelia T, Pitoyo CW, Rumende CM, Amin Z, Pinandari AW, Susanto YDB, Rachmadi L, Rajabto W, Rachman A, Sudoyo AW, Boerma EC, Gondhowiardjo SA, van Geffen WH. PMID: 42784784 [PubMed - indexed for MEDLINE]
	LungRad-BM: Accurately Predicting Brain Metastasis in Non-small Cell Lung Cancer via a Multimodal Deep Learning Framework on (18)F-FDG PET/CT Radiomics. IEEE J Biomed Health Inform Yuan Z, Luo Y, Chen X, Qi N, Zhao J, Huang D, Chen K, Lin S. PMID: 42784496 [PubMed - as supplied by publisher]
	Molecular Residual Disease in Non-Small Cell Lung Cancer: Technology or Patient Outcomes? J Pers Med Walker PR. PMID: 42783485 [PubMed]
	Early Detection of Glottic Cancer Through Machine Learning and Acoustic Voice Analysis: A Systematic Review. Med Sci (Basel) Verma H, Mishra R, Nagamani B, Patro SK, Ramavat AS, Bakshi J, Khandnor P, Rani S, Chand T. PMID: 42783454 [PubMed - indexed for MEDLINE]
	Beyond Lymphovascular Invasion: Site-Dependent Patterns of Lymphatic, Venous and Perineural Involvement in Laryngo-Hypopharyngeal Carcinoma. Med Sci (Basel) Popa RA, Popa CG, Hînganu D, Hînganu MV, Stan CI, Tracicaru RV, Boi. PMID: 42783400 [PubMed - indexed for MEDLINE]
	Cerebral Amyloid Angiopathy-Related Inflammation Mimicking Leptomeningeal Metastasis After Resected Lung Adenocarcinoma: A Case Report Highlighting Dynamic Diagnostic Reassessment. Curr Oncol Shigeyama K, Dotsu Y, Yoshimura S, Hiu T, Ueki N, Futsuki R, Koga S, Honda N, Akagi K, Matsuo M, Taniguchi H, Takemoto S, Mukae H. PMID: 42782908 [PubMed - indexed for MEDLINE]
	Long-Term Cutaneous Hyperpigmentation During Adjuvant Osimertinib Therapy in a Resected Stage IIB EGFR L858R-Mutated Lung Adenocarcinoma in an Older Adult: A Rare Case Report with Two-Year Follow-Up and Literature Review. Curr Oncol Alves MS, Ventura Barros JPQ, Maia DCC, Costa IS, Campos Junior OR, Ribeiro Junior HL. PMID: 42782882 [PubMed - indexed for MEDLINE]
	Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study. Curr Oncol Pierret T, Auliac JB, Ricordel C, Daniel C, Nguyen J, Guisier F, Swalduz A, Curcio H, Desage AL, Bigay-Game L, Huchot E, Falchero L, Doubre H, Bylicki O, Chouaïd C, Greillier L. PMID: 42782857 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 163317

Page 1 of 8166



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy